Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.

Last updated: February 27, 2024
Sponsor: EZUS-LYON 1
Overall Status: Active - Recruiting

Phase

N/A

Condition

Menstruation

Treatment

Hamstring muscles function assessment

Clinical Study ID

NCT05802277
004B2022
  • Ages 18-35
  • Female
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to precise the impact of menstrual cycle and physical activity on the hamstrings muscle function in healthy active women. The main question it aims to answer is : is there a moment of the menstrual cycle when the muscle is better able to recover from a strenuous exercise ? Three appointments will be conducted to evaluate the hamstring muscles at difference moments of the menstrual cycle. Echographic and maximal force production measures will be done.

Researchers will compare these results with a group taking oral contraceptives.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subject aged between 18 and 35 years.

  • Subjects who practice at least 2 hours of sport per week with a competitive aim.

  • Subject who has not presented any musculo-tendinous pathology to the hamstrings in thelast 6 months.

  • Subject with no musculoarticular pathology having a prolonged (more than 2 weeks)interruption of sports activities in the last 2 years.

  • Subject with no muscular pain or pathology currently.

  • Subject with no known cardiac disorders or family history that could present a riskknown family history that could present a risk in case of intense physical effort. physical exertion.

  • Subjects not taking any medication, which in the opinion of the that, in the opinionof the coordinating investigator, may interfere with the evaluation of the studycriteria.

  • Subject able and willing to comply with the protocol and agreeing to give writteninformed consent.

  • Subject affiliated or benefiting from a Social Security plan. Menstrual cycle group:

  • Subject whose last 3 menstrual cycles are of a regular duration (± 4 days maximumdifference between 2 consecutive menstrual cycles).

  • Subject whose last 3 menstrual cycles are of a duration between 24 and 32 days (including milestones).

  • Absence of any contraceptive method likely to modulate the hormonal variations linkedto the menstrual cycle. hormonal variations related to the menstrual cycle, during the duration of the duration ofthe protocol and during the last 6 months after the participant's inclusion. the participant. Mechanical contraception such as the diaphragm is permitted. Oral contraceptive group:

  • Taking oral contraception, 2nd generation monophasic pill estrogen-progestin pill (Optilova®, Optidril®, Leeloo®, Minidril®, Ludeal®, Zikiale®, Lovavulo®, Lovapharm®) for atleast 6 months.

Exclusion

Exclusion Criteria:

  • Subjects with a medical contraindication to intense physical activity.
  • Subject with a positive pregnancy test result.
  • Subject with a medical or surgical history deemed by the coordinating investigator asbeing incompatible with the study.
  • Subjects under guardianship.
  • Subjects in a period of exclusion from another study.
  • Decision of the volunteer, whatever the reason.
  • Adverse event or effect affecting the safety of the volunteer in the opinion of thecoordinating investigator.
  • Major deviation from the protocol.
  • Illness or injury interfering with the normal course of the protocol.

Study Design

Total Participants: 130
Treatment Group(s): 1
Primary Treatment: Hamstring muscles function assessment
Phase:
Study Start date:
October 05, 2022
Estimated Completion Date:
April 01, 2024

Connect with a study center

  • Laboratoire Interuniversitaire de Biologie de la Motricité

    Villeurbanne, Rhône 69622
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.